home / stock / aclx / aclx articles

ACLX Articles, Arcellx Inc.

Stock Information
Company Name: Arcellx Inc.
Stock Symbol: ACLX
Market: NASDAQ
Website: arcellx.com
Menu
ACLX ACLX Quote ACLX Short ACLX News ACLX Articles ACLX Message Board
Get ACLX Alerts

News, Short Squeeze, Breakout and More Instantly...
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley | Benzinga

Morgan Stanley initiates Arcellx Inc (NASDAQ:ACLX), noting a differentiated CAR-T platform for blood cancer backed by an established...
Arcellx Analysts Boost Their Forecasts After Q4 Results | Benzinga

Arcellx, Inc. (NASDAQ: ACLX) posted financial results for its fourth quarter on Wednesday. The company posted net income of $20.5 million for the q...

Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024 | Benzinga

Needham analyst forecasts a positive outlook for Arcellx Inc (NASDAQ:ACLX) in 2024, citing strong potential stemming from the anticipated pivotal...

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results. Johnson Contr...
Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say | Benzinga

Friday, Arcellx Inc (NASDAQ: ACLX) announced new data from its Phase 1 expansion study of CART-ddBCMA, now known as anitocabtagene autole...

Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholder...

Why Is Blood Cancer Focused Arcellx Stock Trading Higher Today? | Benzinga

Arcellx Inc (NASDAQ: ACLX) announced that new clinical data from its Phase 1 study of CART-ddBCMA in patients with relapsed or refractory mult...
Next 10